首页 › 基金 › Affinity Asset Advisors, LLC › ABVX

Affinity Asset Advisors, LLC 对 ABVX 的持仓历史

ABIVAX SA · 医疗保健

Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 ABVX(ABIVAX SA)330,000 股,市值约 US$32.7M,约占其申报组合的 1.52%,在其申报持仓中市值排名第 17 位。 Affinity Asset Advisors, LLC 最近 7 个申报季度中有 7 个季度披露了 ABVX 持仓,最早可追溯至 Q1 2025。

最新持仓 (Q3 2026)330.00K 股
申报持仓市值$32.68M
组合权重1.52%
首次申报Q1 2025
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Affinity Asset Advisors, LLC 对 ABVX 的持仓演变

Affinity Asset Advisors, LLC 于 Q1 2025 首次披露 ABVX 持仓:200,000 股(约 US$1.2M)。 该持仓在 Q4 2025 达到峰值 505,000 股,市值约 US$68.1M。 在 7 次申报中,Affinity Asset Advisors, LLC 2 次增持、3 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 330,000 股、市值约 US$32.7M。 持仓曾出现大幅变动:Q2 2025 减持约 50% (随后一个季度股价上涨 1010%)、Q3 2025 增持约 260% (随后一个季度股价上涨 59%)、Q4 2025 增持约 40% (随后一个季度股价下跌 17%)。

逐季持仓明细

季度股数金额变化
Q1 2025 200.00K $1.25M 新进
Q2 2025 100.00K $765.00K 减持
Q3 2025 360.00K $30.56M 增持
Q4 2025 505.00K $68.10M 增持
Q1 2026 405.00K $45.10M 减持
Q2 2026 330.00K $43.98M 减持
Q3 2026 330.00K $32.68M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABVX 与 13F 数据

ABVX(ABIVAX SA)属于医疗保健行业。我们追踪的基金中还有 70 只申报持有 ABVX,申报仓位最大的包括:TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABVX 的基金

查看 ABVX 的全部基金持有人 →

常见问题

How long has Affinity Asset Advisors, LLC held ABVX?

Affinity Asset Advisors, LLC has disclosed ABVX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Affinity Asset Advisors, LLC's current position in ABVX?

As of Q3 2026, Affinity Asset Advisors, LLC holds 330.00K shares of ABVX (ABIVAX SA), valued at $32.68M, representing 1.52% of its reported portfolio and ranking #17.

Has Affinity Asset Advisors, LLC been buying or selling ABVX?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in ABVX. The position peaked in Q4 2025 at 505.00K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.